Literature DB >> 21370190

Methods for the Serum-Free Culture of Keratinocytes and Transplantation of Collagen-GAG-Based Skin Substitutes.

S T Boyce1.   

Abstract

Objectives for dermal-epidermal skin substitutes for treatment of acute and chronic wounds include, but are not limited to: increased availability; stimulation of wound healing by transplantation of parenchymal cells; regulation of wound healing responses; and, predictable composition and efficacy to reduce mortality and morbidity. Particularly, the importance of including a cellular component has been demonstrated in experimental grafts of cells and biopolymers (1-7). Transplanted cells may include normal, nontransformed populations isolated for primary culture, or genetically modified cells to deliver specific gene products of therapeutic interest (8-10). Nontransformed cells may include autologous, allogeneic, or chimeric populations within composite grafts. A variety of approaches are directed toward repair of skin wounds by restoration of the functional anatomy and physiology of skin.

Year:  1999        PMID: 21370190     DOI: 10.1385/0-89603-516-6:365

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  16 in total

1.  Randomized, Paired-Site Comparison of Autologous Engineered Skin Substitutes and Split-Thickness Skin Graft for Closure of Extensive, Full-Thickness Burns.

Authors:  Steven T Boyce; Peggy S Simpson; Mary T Rieman; Petra M Warner; Kevin P Yakuboff; J Kevin Bailey; Judith K Nelson; Laura A Fowler; Richard J Kagan
Journal:  J Burn Care Res       Date:  2017 Mar/Apr       Impact factor: 1.845

2.  Development of the mechanical properties of engineered skin substitutes after grafting to full-thickness wounds.

Authors:  Edward A Sander; Kaari A Lynch; Steven T Boyce
Journal:  J Biomech Eng       Date:  2014-05       Impact factor: 2.097

3.  Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice.

Authors:  Dorothy M Supp; Kaila Wilson-Landy; Steven T Boyce
Journal:  FASEB J       Date:  2002-06       Impact factor: 5.191

4.  Controlled-rate freezing to regulate the structure of collagen-glycosaminoglycan scaffolds in engineered skin substitutes.

Authors:  Christopher Lloyd; John Besse; Steven Boyce
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2014-08-18       Impact factor: 3.368

5.  Tie-Over Bolster Pressure Dressing Improves Outcomes of Skin Substitutes Xenografts on Athymic Mice.

Authors:  Andréanne Cartier; Martin A Barbier; Danielle Larouche; Amélie Morissette; Ariane Bussières; Livia Montalin; Chanel Beaudoin Cloutier; Lucie Germain
Journal:  Int J Mol Sci       Date:  2022-05-14       Impact factor: 6.208

6.  Platelet lysate can support the development of a 3D-engineered skin for clinical application.

Authors:  I Banakh; Md M Rahman; C L Arellano; D C Marks; S Mukherjee; C E Gargett; H Cleland; S Akbarzadeh
Journal:  Cell Tissue Res       Date:  2022-10-22       Impact factor: 4.051

Review 7.  Xenobiotic bioconversion in human epidermis models.

Authors:  Audra L Stinchcomb
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

8.  Assessment of replication rates of human keratinocytes in engineered skin substitutes grafted to athymic mice.

Authors:  Steven T Boyce; Rachel K Rice; Kaari A Lynch; Andrew P Supp; Viki B Swope; Richard J Kagan; Dorothy M Supp
Journal:  Wound Repair Regen       Date:  2012-06-07       Impact factor: 3.401

9.  Analysis of chromatin accessibility in human epidermis identifies putative barrier dysfunction-sensing enhancers.

Authors:  Julie M Lander; Dorothy M Supp; Hua He; Lisa J Martin; Xiaoting Chen; Matthew T Weirauch; Steven T Boyce; Raphael Kopan
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

10.  Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1.

Authors:  Jennifer M Hahn; Kevin L McFarland; Kelly A Combs; Dorothy M Supp
Journal:  Burns Trauma       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.